GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
75 hedge funds and large institutions have $229M invested in Global Blood Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 14 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
51% less capital invested
Capital invested by funds: $470M → $229M (-$241M)
Holders
75
Holding in Top 10
2
Calls
$17.6M
Puts
$10K
Top Buyers
| 1 | +$5.26M | |
| 2 | +$3.3M | |
| 3 | +$3.17M | |
| 4 |
IHM
Iguana Healthcare Management
New York
|
+$2.22M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.78M |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$9.6M | |
| 3 | -$9.17M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$7.07M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.27M |